Financial Gravity Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-47
| Closed | -$176 | – | 2197 |
|
|
2024
Q1 | $176 | Buy |
47
+37
| +370% | +$139 | ﹤0.01% | 1631 |
|
|
2023
Q4 | $78 | Buy |
10
+5
| +100% | +$39 | ﹤0.01% | 1285 |
|
|
2023
Q3 | $32 | Sell |
5
-8
| -62% | -$51 | ﹤0.01% | 1083 |
|
|
2023
Q2 | $289 | Buy |
13
+1
| +8% | +$22 | ﹤0.01% | 1075 |
|
|
2023
Q1 | $8 | Buy |
12
+4
| +50% | +$3 | ﹤0.01% | 883 |
|
|
2022
Q4 | $146 | Sell |
8
-4
| -33% | -$73 | ﹤0.01% | 1047 |
|
|
2022
Q3 | $4 | Buy |
12
+4
| +50% | +$1 | ﹤0.01% | 795 |
|
|
2022
Q2 | $3 | Sell |
8
-10
| -56% | -$4 | ﹤0.01% | 715 |
|
|
2022
Q1 | $6 | Sell |
18
-22
| -55% | -$7 | ﹤0.01% | 795 |
|
|
2021
Q4 | $14 | Buy |
40
+39
| +3,900% | +$14 | ﹤0.01% | 840 |
|
|
2021
Q3 | $26K | Hold |
1
| – | – | 0.01% | 742 |
|
|
2021
Q2 | $35K | Sell |
1
-1
| -50% | -$35K | 0.01% | 674 |
|
|
2021
Q1 | $70 | Buy |
+2
| New | +$70 | ﹤0.01% | 527 |
|